Medical Nutrition gains ground in institutions
This article was originally published in The Tan Sheet
Executive Summary
The maker of nutritional products for medical patients reports a 24 percent jump in sales to $4.1 million for the three months ended July 31. Medical Nutrition USA said Sept. 10 it eked out net income of $125,000 in its fiscal 2010 second quarter, compared to a $183,700 loss in the year-ago period. CEO Frank Newman attributed the improvements to "increased product line breadth and greater penetration of the nursing home, hospital and dialysis markets." The Englewood, N.J., firm recently launched a new formulation of its Fiber-Stat with added prune juice concentrate. Medical Nutrition also makes Pro-Stat, UTI-Stat and private-label productsYou may also be interested in...
Biogen’s Big Day Arrives, But Aducanumab Results Don’t Answer Key Question
Biogen presented highly anticipated data in Alzheimer’s disease at CTAD for its Phase III EMERGE and ENGAGE studies, but one major question remains unanswered: will the FDA approve the drug?
Biogen’s Big Day Arrives, But Aducanumab Results Don’t Answer Key Question
Biogen presented highly anticipated data in Alzheimer’s disease at CTAD for its Phase III EMERGE and ENGAGE studies, but one major question remains unanswered: will the FDA approve the drug?
Sage Still Sees Approval Path After Depression Drug Fails In Phase III Trial
Sage Therapeutics points to patient compliance and selection as factors in its failed trial of SAGE-217. The company sees positive implications in the data as it waits for other SAGE-217 studies.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: